Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.
5 Things From the Task Force on Mental Health Parity
Audits, consumer education, and help for states were among the recommendations to force better compliance with the 2008 law, which seeks to ensure that coverage for mental health or substance abuse disorders mirrors other benefits in a health plan.
CMS Sets Eligibility Rules for Medicare Diabetes Prevention Program
The program has been shown to reduce by 58% the likelihood of progressing to type 2 diabetes. Reimbursement details are still being worked out, but CMS clarified that Medicare patients will not be subject to cost-sharing.
Public Wants Next President, Congress to Tackle Drug Prices
Frustration with high prescription drug prices remains an issue that cuts across party lines. Majorities of Democrats, Republicans, and independents want the government to protect access to high-cost treatments for those with chronic conditions.
Myriad RBM, Sanofi, Reach Deal to Measure Predictive CV Markers in Diabetes Patients
Ralph McDade, PhD, Myriad RBM's president, explained earlier this year how the precision medicine approach, pioneered in oncology, was finding its way into the cardiovascular arena, and that it could ultimately lead to develop of a risk panel that would make the ELIXA trial simpler and less costly.
Troubles on the Exchanges Will Confront the Next President, Experts Say
Panelists in the Healthcare 2020 series discuss the challenges with the exchanges that will be waiting for the next president, the future of Medicaid expansion, and how the complexity of so many models is burdening ACOs.
Omnipod Feasibility Study Seeks to Perfect Formulas That Will Make Artificial Pancreas Run
Current work seeks to perfect the algorithm that would someday let the insulin pump automatically make the multitude of delivery decisions that would have been made by a healthy pancreas. Advances are happening alongside a shifting landscape in payer coverage, with advocates worried that they might lack choice amid so much innovation.